Where Sourcing Meets Science: Performance Improvement And Cost Reduction Through Innovative Collaboration

Consistent, optimized cell culture media is essential to achieving robust performance, cost control, and supply reliability in biotherapeutic manufacturing. However, variability in raw material attributes—particularly in complex components such as peptones and yeast extracts—can introduce risk, reduce yields, and increase operational costs. This session examines how collaborative approaches between developers and suppliers can systematically reduce raw material variability while preserving the performance advantages of complex nutrients.

With a focus on animal-free peptones and yeast extracts, the discussion highlights how structured Variability Reduction Programs enable fit-for-function materials through tighter control of critical attributes such as trace minerals. Real-world case studies illustrate measurable improvements in cell growth, viability, and product titers across development and commercial manufacturing. Quantitative models further demonstrate how raw material optimization translates into meaningful cost efficiencies and revenue impact. By aligning sourcing strategy with scientific insight, manufacturers can unlock higher productivity, enhanced material control, and reduced risk across the biotherapeutic lifecycle.